Improved Immunogenicity of Biodegradable Polymer Particles Entrapped Rotavirus Vaccine
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Rotavirus (RV) entrapped in polylactide (PLA) and polylactide-coglycolide (PLGA) polymer particles were formulated and evaluated in mice for improved immunogenicity using oral, intranasal (IN), and intramuscular (IM) routes of administration. Microparticles of size ranges between 1 and 8 µm were prepared using double emulsion solvent evaporation technique. Stabilizers like mouse serum albumin, sucrose, and sodium bicarbonate that were used during particle formulation helped in minimizing the denaturation of the entrapped antigen. Immunization with 20 µg of antigen entrapped in polymeric particles through various routes of administration elicited measurable amount of antibody titer in mice. The immunoglobulin A (IgA) and immunoglobulin G (IgG) titer (≥4-fold rise between pre and post immunized sera) was analyzed by the use of enzyme-linked immunosorbent assay. PLGA encapsulated RV microparticles elicited better antibody response through IN route (90%) where as PLA encapsulated RV microparticles showed improved response when administrated through oral route (83.3%). Overall, the performance of IN route based immunization was significantly higher than oral and IM route ( p<0.001) with both the polymers. The results are of indication that, PLGA encapsulated RV microparticles have greater potential for vaccine formulation to combat rotavirus infection.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Oral immunomodulation with polymeric particulate carriers has been investigated for a wide range of therapeutic applications, such as immuno suppressive drugs [42], viral and bacterial antigens [58,65], hormones [5,73], anticancer drugs [74], and allergens [75].”
From Use of lectin-functionalized particles for oral immunotherapy (2012) · cites this paper as [58]
In the citing paper
“Particle structures smaller than 5 μm are taken up by APCs, such as dendritic cells (DCs) and macrophages [59–61], and are transported directly to the lymph node [58], where the encapsulated antigen can be presented to T cells.”
From Use of lectin-functionalized particles for oral immunotherapy (2012) · cites this paper as [58]
In the citing paper
“Only MPs between 1 and 10 μm in size promote humoral responses, whereas NPs below 1 μm mainly induce cellular responses (Figure 1) [58].”
From Use of lectin-functionalized particles for oral immunotherapy (2012) · cites this paper as [58]
In the citing paper
“Orally applied PLA microspheres induced a more persistent and longer-lasting serum IgA antibody response, which could be explained by the higher hydro phobicity of PLA and the slower polymer degradation.”
From Use of lectin-functionalized particles for oral immunotherapy (2012) · cites this paper as [58]
In the citing paper
“PLGA microspheres showed an improved antibody response when being applied via the intranasal route.”
From Use of lectin-functionalized particles for oral immunotherapy (2012) · cites this paper as [58]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Rotavirus and Severe Childhood Diarrhea
Parashar, U. D., Gibson, C. J., Bresee, J. S., & Glass, R. I. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1202.050006 · Cited by 1,470
Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells
Mora, J. R., Bono, M. R., Manjunath, N., Weninger, W., Cavanagh, L. L., Rosemblatt, M., & von Andrian, U. H. (2003) · Nature · doi:10.1038/nature01726 · Cited by 1,074
Intussusception among Infants Given an Oral Rotavirus Vaccine
Murphy, T. V., Gargiullo, P. M., Massoudi, M. S., Nelson, D. B., Jumaan, A. O., Okoro, C. A., Zanardi, L. R., Setia, S., Fair, E., LeBaron, C. W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102223440804 · Cited by 973
JIANG, W., GUPTA, R., DESHPANDE, M., & SCHWENDEMAN, S. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.003 · Cited by 478
Joensuu, J., Koskenniemi, E., Pang, X.-L., & Vesikari, T. (1997) · The Lancet · doi:10.1016/s0140-6736(97)05118-0 · Cited by 312
Kanchan, V., & Panda, A. K. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.08.015 · Cited by 283
Self-citationDennehy, P. H. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.01.102 · Cited by 281
Davis, S. S. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00162-4 · Cited by 274
Immunity and correlates of protection for rotavirus vaccines
Franco, M. A., Angel, J., & Greenberg, H. B. (2006) · Vaccine · doi:10.1016/j.vaccine.2005.12.048 · Cited by 268
The Role of Serum Antibodies in the Protection against Rotavirus Disease: An Overview
Jiang, B., Gentsch, J. R., & Glass, R. I. (2002) · Clinical Infectious Diseases · doi:10.1086/340103 · Cited by 208
Human rotavirus enteritis induced in conventional piglets. Intestinal structure and transport.
Davidson, G. P., Gall, D., Petrić, M., Butler, D. G., & Hamilton, J. R. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108901 · Cited by 167
Kapikian, A. Z., Wyatt, R. G., Levine, M. M., Yolken, R. H., VanKirk, D. H., Dolin, R., Greenberg, H. B., & Chanock, R. M. (1983) · Journal of Infectious Diseases · doi:10.1093/infdis/147.1.95 · Cited by 162
Controlled release microparticles for vaccine development
O’Hagan, D. T., Jeffery, H., Roberts, M. J. J., McGee, J. P., & Davis, S. S. (1991) · Vaccine · doi:10.1016/0264-410x(91)90295-h · Cited by 149
Katare, Y. K., Muthukumaran, T., & Panda, A. K. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.05.028 · Cited by 143
Self-citationCahill, E., O'Hagan, D. T., Illum, L., Barnard, A., Mills, K. H., & Redhead, K. (1995) · Vaccine · doi:10.1016/0264-410x(94)00008-b · Cited by 101
Azevedo, M. S. P., Yuan, L., Jeong, K.-I., Gonzalez, A., Nguyen, T. H. T., Pouly, S., Gochnauer, M. B., Zhang, W., Azevedo, A. C., & Saif, L. J. (2005) · Journal of Virology · doi:10.1128/jvi.79.9.5428-5436.2005 · Cited by 97
Kim, B. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00280-8 · Cited by 93
Pathogenesis of rotavirus-induced diarrhea: Preliminary studies in miniature swine piglet
Graham, D. Y., Sackman, J. W., & Estes, M. K. (1984) · Digestive Diseases and Sciences · doi:10.1007/bf01311255 · Cited by 90
Serum IgG mediates mucosal immunity against rotavirus infection
Westerman, L. E., McClure, H. M., Jiang, B., Almond, J. W., & Glass, R. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502437102 · Cited by 82
Yuan, L., Wen, K., Azevedo, M. S., González, A., Zhang, W., & Saif, L. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.03.085 · Cited by 81
Effect of excipients on PLGA film degradation and the stability of an incorporated peptide
Houchin, M. L., Neuenswander, S. A., & Topp, E. M. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.11.023 · Cited by 76
Barackman, J. D., Ott, G. S., & O’Hagan, D. T. (1999) · Infection and Immunity · doi:10.1128/iai.67.8.4276-4279.1999 · Cited by 73
Enhancement of Rotavirus Immunogenicity by Microencapsulation
Offit, P. A., Khoury, C. A., Moser, C. A., Clark, H. F., Kim, J. E., & Speaker, T. J. (1994) · Virology · doi:10.1006/viro.1994.1463 · Cited by 69
VanCott, J. L., Prada, A. E., McNeal, M., Stone, S. C., Basu, M., Huffer, B., Smiley, K. L., Shao, M., Bean, J. A., Clements, J. D., et al. (2006) · Journal of Virology · doi:10.1128/jvi.80.10.4949-4961.2006 · Cited by 69
Stabilization of Dichloromethane-Induced Protein Denaturation During Microencapsulation
Raghuvanshi, R. S., Goyal, S., Singh, O., & Panda, A. K. (1998) · Pharmaceutical Development and Technology · doi:10.3109/10837459809028504 · Cited by 68
Self-citationGreen, K. Y., & Kapikian, A. Z. (1992) · Journal of Virology · doi:10.1128/jvi.66.1.548-553.1992 · Cited by 66
Chambin, O., Champion, D., Debray, C., Rochat-Gonthier, M. H., Meste, M. L., & Pourcelot, Y. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.11.009 · Cited by 62
Clinical update: rotavirus gastroenteritis and its prevention
Grimwood, K., & Buttery, J. P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61142-8 · Cited by 59
Isaka, M., Yasuda, Y., Kozuka, S., Taniguchi, T., Matano, K., Maeyama, J., Komiya, T., Ohkuma, K., Goto, N., & Tochikubo, K. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00258-3 · Cited by 54
Srinivasan, C., Katare, Y. K., Muthukumaran, T., & Panda, A. K. (2005) · Journal of Microencapsulation · doi:10.1080/02652040400026400 · Cited by 50
Self-citationRay, P., Malik, J., Singh, R. K., Bhatnagar, S., Bahl, R., Kumar, R. K., & Bhan, M. K. (2003) · The Journal of Infectious Diseases · doi:10.1086/375243 · Cited by 47
Self-citationMena, J. A., Ramírez, O. T., & Palomares, L. A. (2005) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2005.10.005 · Cited by 43
Khoury, C. A., Moser, C. A., Speaker, T. J., & Offit, P. A. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/172.3.870 · Cited by 42
Issues with reducing the rotavirus-associated mortality by vaccination in developing countries
Naghipour, M., Nakagomi, T., & Nakagomi, O. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.04.004 · Cited by 41
Drug release from reservoir pellets compacted with some excipients of different physical properties
Tunón, Å., Börjesson, E., Frenning, G., & Alderborn, G. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2003.09.009 · Cited by 39
Periwal, S. B., Speaker, T. J., & Cebra, J. J. (1997) · Journal of Virology · doi:10.1128/jvi.71.4.2844-2850.1997 · Cited by 38
McNeal, M., Basu, M., Bean, J. A., Clements, J. D., Choi, A. H.-C., & Ward, R. L. (2007) · Virology · doi:10.1016/j.virol.2007.01.041 · Cited by 33
Assessing the introduction of universal rotavirus vaccination in the Netherlands
Zomer, T. P., van Duynhoven, Y. T. H. P., Mangen, M.-J. J., van der Maas, N., Vennema, H., Boot, H. J., & de Melker, H. E. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.04.039 · Cited by 33
Formulation and Characterization of Immunoreactive Tetanus Toxoid Biodegradable Polymer Particles
Raghuvanshi, O. S. (2001) · Drug Delivery · doi:10.1080/107175401750177089 · Cited by 32
Johansson, E., Istrate, C., Charpilienne, A., Cohen, J., Hinkula, J., Poncet, D., Svensson, L., & Johansen, K. (2008) · Vaccine · doi:10.1016/j.vaccine.2007.11.089 · Cited by 24
García-Díaz, A., López-Andújar, P., Rodríguez‐Díaz, J., Montava, R., Barceló, C. T., Ribes, J. M., & Buesa, J. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.06.018 · Cited by 22
Dennehy, P. H., Rodgers, G. C., Ward, R. L., MARKWICK, A. J., MACK, M., & Zito, E. T. (1996) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199611000-00016 · Cited by 18
Rotavirus and calicivirus infections of the gastrointestinal tract
Ciarlet, M., & Estes, M. K. (2001) · Current Opinion in Gastroenterology · doi:10.1097/00001574-200101000-00003 · Cited by 13
Research works printed but not linked: 4
- Parashar, U.D., 2006, Ther. Strat., 3, 159
- McGhee, J.R. ( 1992). Mucosal-associated Lymphoid Tissue (MALT), In: Roitt, I.M. and Delves, P.J. (eds), Encyclopedia of Immunology, San Diego, Academic Press, pp. 1110-1114.
- Barackman, J.D., 1997, Infect. Immun., 67, 4267
- Ciarlet, A.B., 2003, Intranasally, or Orally to Mice, Vaccine, 21, 3885
Cited by
Nayak, D., Pradhan, S., Ashe, S., Rauta, P. R., & Nayak, B. (2015) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2015.07.012 · Cited by 233
Self-citationUse of lectin-functionalized particles for oral immunotherapy
Diesner, S. C., Wang, X.-Y., Jensen-Jarolim, E., Untersmayr, E., & Gabor, F. (2012) · Therapeutic Delivery · doi:10.4155/tde.11.146 · Cited by 40
Bouriche, S., Cózar-Bernal, M. J., Rezgui, F., Álvarez, A. M. R., & González-Rodríguez, M. L. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.03.011 · Cited by 37
Development of Yersinia pestis F1 antigen-loaded microspheres vaccine against plague
Yeh, M., Huang, S.-S., Li, I., & Hong, P. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s56260 · Cited by 36
Gao, L., Li, Q., Zhao, Y., Wang, H., Liu, Y., Sun, Y., Wang, F., Jia, W., & Hou, X. (2017) · IET Nanobiotechnology · doi:10.1049/iet-nbt.2016.0207 · Cited by 29
Metadata
- Authors
- Nayak, B., Ray, A. R., Panda, A. K., & Ray, P.
- Affiliations
- All India Institute of Medical Sciences (IN)
- National Institute of Immunology (IN)
- Corresponding author
- Ray, Alok R.
- Venue
- Journal of Biomaterials Applications
- Publisher
- SAGE Publications
- Published
- 2010-03-05
- Volume
- 25
- Issue
- 5
- Pages
- 469-496
- ISSN
- 0885-3282 (ISSN-L)
- 1530-8022
- OpenAlex
- W2013968685
- Cited by
- 10
- References
- 43
- Citations by year
- 2026: 1 · 2025: 1 · 2023: 1 · 2021: 1 · 2019: 1 · 2017: 1 · 2015: 1 · 2014: 2 · 2012: 1
- FWCI
- 0.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Biomaterials Applications (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Health Sciences › Medicine › Infectious Diseases › Viral gastroenteritis research and epidemiology
- Life Sciences › Agricultural and Biological Sciences › Food Science › Microencapsulation and Drying Processes
- Keywords
- rotavirus vaccine, polylactic acid, oral immunization, intranasal immunization, intramuscular vaccination, double emulsion solvent evaporation, antigen encapsulation, immunogenicity, antibody response, vaccine adjuvants
- MeSH terms
- Polylactic Acid-Polyglycolic Acid Copolymer, Administration, Intranasal, Administration, Oral, Animals, Antibodies, Viral, Biocompatible Materials, Child, Drug Carriers, Drug Compounding, Humans, Immunoglobulin A, Immunoglobulin G, Injections, Intramuscular, Materials Testing, Mice, Inbred BALB C, Microscopy, Electron, Scanning, Microspheres, Particle Size, Polyesters, Polyglycolic Acid, Rotavirus Infections, Surface Properties, Time Factors, Drug Delivery Systems, Microscopy, Atomic Force, Lactic Acid, Rotavirus Vaccines, Models, Animal, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.